Managing type 2 diabetes effectively requires a combination of lifestyle changes, diet, and medications that can maintain blood sugar levels within the recommended range. GLIEMPAFLOZIN MET 5mg/1000mg, combining Empagliflozin 5 mg and Metformin Hydrochloride 1000 mg, is an innovative dual-action therapy designed to help patients achieve optimal glycemic control while supporting cardiovascular and metabolic health. This combination simplifies treatment regimens, improves adherence, and provides a reliable solution for patients who struggle with uncontrolled blood glucose levels.
Introduction: What is GLIEMPAFLOZIN MET 5mg/1000mg?
GLIEMPAFLOZIN MET is an oral antidiabetic medication that combines:
Empagliflozin (5 mg): An SGLT2 inhibitor that reduces glucose reabsorption in the kidneys and promotes its excretion via urine, helping lower blood sugar and support heart health.
Metformin Hydrochloride (1000 mg): A biguanide that decreases hepatic glucose production and improves insulin sensitivity, supporting long-term glucose regulation
This combination targets both fasting and postprandial blood glucose levels, making GLIEMPAFLOZIN MET a preferred choice for patients requiring dual-action therapy.
Composition of GLIEMPAFLOZIN MET 5mg/1000mg
Each tablet contains:
Empagliflozin IP – 5 mg
Metformin Hydrochloride IP – 1000 mg
Excipients – q.s.
This formulation ensures effective glycemic control while reducing pill burden, promoting better adherence in daily diabetes management.
Mechanism of Action
Empagliflozin (5 mg):
Inhibits sodium-glucose co-transporter 2 (SGLT2) in the renal tubules
Reduces glucose reabsorption, increasing urinary glucose excretion
Supports mild weight reduction and cardiovascular health
Metformin Hydrochloride (1000 mg):
Decreases hepatic gluconeogenesis, reducing glucose production
Enhances peripheral glucose uptake and insulin sensitivity
Maintains stable fasting blood glucose levels
The combination addresses both insulin resistance and renal glucose handling, offering comprehensive glucose-lowering effects.
Key Benefits of GLIEMPAFLOZIN MET 5mg/1000mg
Dual Mechanism for Glycemic Control: Tackles both insulin-dependent and independent pathways for effective blood sugar management.
Weight Management: Empagliflozin contributes to modest weight loss through urinary glucose excretion.
Cardiovascular Protection: Empagliflozin has been clinically shown to reduce the risk of heart failure and improve cardiovascular outcomes.
Convenient Once-Daily Dosing: Simplifies treatment and enhances patient adherence.
Improved Insulin Sensitivity: Metformin helps reduce insulin resistance, improving overall glucose utilization
Lower Risk of Hypoglycemia: Provides effective glycemic control without significantly increasing the risk of low blood sugar.
How to Take GLIEMPAFLOZIN MET
Dosage: Take once daily or as prescribed by your healthcare provider.
Administration: Swallow the tablet whole with water; avoid crushing or chewing.
Timing: Can be taken with meals to reduce gastrointestinal discomfort from Metformin.
Monitoring: Regular blood glucose checks and periodic kidney and liver function tests are recommended.
Important: Never adjust your dose without consulting a doctor.
Who Should Use GLIEMPAFLOZIN MET?
Adults with type 2 diabetes inadequately controlled on monotherapy
Patients needing dual-action therapy for fasting and postprandial glucose control
Individuals with high cardiovascular risk seeking additional heart protection
Patients who prefer once-daily oral therapy to simplify diabetes management
Precautions and Safety Information
Kidney Function: Patients with severe renal impairment should avoid Empagliflozin; kidney function should be monitored.
Hydration: Maintain adequate fluid intake to prevent dehydration due to Empagliflozin’s diuretic effect.
Hypoglycemia: Low risk, but may increase if combined with insulin or sulfonylureas.
Allergic Reactions: Seek immediate medical attention for rash, swelling, or difficulty breathing
Pregnancy & Lactation: Consult a healthcare professional before use.
Possible Side Effects
Common side effects may include:
Increased urination and mild thirst (from Empagliflozin)
Gastrointestinal issues such as nausea, diarrhea, or abdominal discomfort (from Metformin)
Rare urinary tract or genital infections
Mild fatigue or dizziness
Most side effects are manageable and often subside with proper hydration and medical supervision.
Why Choose Steris Healthcare for GLIEMPAFLOZIN MET?
Steris Healthcare Pvt. Ltd. is a trusted pharmaceutical company committed to patient safety and quality medication delivery. Choosing GLIEMPAFLOZIN MET from Steris ensures:
High-quality manufacturing under strict GMP standards
Accurate formulation for consistent efficacy
Patient-focused solutions designed to improve adherence and quality of life
Reliable access to safe and affordable medications
Steris Healthcare combines innovation, quality, and reliability, making it a brand that patients and healthcare providers trust.
Patient Perspective
Patients taking GLIEMPAFLOZIN MET experience:
Convenience: Single tablet, once daily
Stable Blood Sugar Levels: Improved fasting and postprandial control
Support for Heart Health and Weight Management
Simplified Diabetes Care: Reduced pill burden and therapy complexity
Patients often report greater confidence in managing their diabetes and improved overall quality of life while on this combination therapy.
Frequently asked questions
Q1. What is GLIEMPAFLOZIN MET used for?
It is prescribed for type 2 diabetes to manage blood sugar and provide cardiovascular benefits.
Q2. Can it be taken with other medications?
Yes, under medical supervision, especially when combined with insulin or other oral hypoglycemic agents.
Q3. How should it be taken?
Once daily with water; taking with meals may reduce gastrointestinal discomfort.
Q4. Are there dietary restrictions?
Maintain a balanced diet, stay hydrated, and limit excessive alcohol intake.
Q5. Can patients with kidney problems take it?
Consult a doctor before use if there is moderate or severe renal impairment.
Q6. Are regular check-ups necessary?
Yes, monitoring of blood glucose, kidney, and liver functions is recommended.
Conclusion
GLIEMPAFLOZIN MET 5mg/1000mg offers a powerful dual-action therapy combining Empagliflozin and Metformin Hydrochloride, targeting both fasting and postprandial blood sugar effectively. With the trusted quality of Steris Healthcare Pvt. Ltd., patients can rely on safe, consistent, and high-quality medication for long-term diabetes management. This combination simplifies therapy, improves adherence, and supports better metabolic and cardiovascular outcomes, making it an ideal choice for adults managing type 2 diabetes.
For further information:
📩 Email: info@sterispharma.com / contact@sterispharma.com
📞 Call/WhatsApp: 8209542042, 8824175417
👉BUY NOW
